Some forecasts have predicted the nanotechnology market to reach close to a trillion dollars by 2015, presenting investors with unique opportunities. However, the market for applications of nanotechnology is complex, multidisciplinary and highly segmented. It is therefore essential to gain an understanding of which market sectors nanotechnology is likely to impact most profoundly in the near term.
That’s what we do at Cientifica.
Since we now know most (if not all) biological processes occur at the nanoscale, the application of life science principles – studying the causes of biological phenomena at the molecular level – means medical and biomedical research is increasingly using a bottom-up rather than the traditional top-down approach, and it is also the area which all our data points to as giving the highest returns from the application of nanotechnologies.
So today we release the first fruits of a major research program we have been undertaking, trying to understand the relationship between nanotechnology and medicine, and to generate some useful market predictions of the kind that are both rational and accurate.
Nanotechnology in Drug Delivery 2011 provides an in-depth presentation of recent developments in nanotech drug delivery (NDD) and provides market opportunities to 2021, for the largest economies in the Americas, Asia, Europe and the rest of the world.
To get to our market forecasts for NDD from 2011 to 2021 we also had to determine the historical market growth for NDD between 2000-2010, which meant wading through a mire of disinformation and speculation (as well as sifting through thousands of publications).
Unusually for this kind of report, we can now segment the market by geographical region and by technology type.
We examined every kind of technology types examined including: solubility & bioavailability, targeted delivery, drug nanocrystals, liposomes, carbon nanotubes, gold nanocarriers, dendrimers, micelles, polymer-based nanocarriers, nanoshells, ceramic nanocarriers, calcium phosphate nanocarriers and many more.
So where is the opportunity? We recommend looking at liposomes, drug nanocrystals and gold nanoparticles, and reading Nanotechnology in Drug Delivery 2011 will tell you why.